- Home
- LYT vs ISPC Comparison
LYT vs ISPC Comparison
Compare LYT & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYT
- ISPC
- Stock Information
- Founded
- LYT 2020
- ISPC 2009
- Country
- LYT India
- ISPC United States
- Employees
- LYT N/A
- ISPC N/A
- Industry
- LYT EDP Services
- ISPC Precision Instruments
- Sector
- LYT Technology
- ISPC Health Care
- Exchange
- LYT Nasdaq
- ISPC Nasdaq
- Market Cap
- LYT 1.8M
- ISPC 2.0M
- IPO Year
- LYT 2022
- ISPC 2021
- Fundamental
- Price
- LYT $0.27
- ISPC $1.74
- Analyst Decision
- LYT
- ISPC
- Analyst Count
- LYT 0
- ISPC 0
- Target Price
- LYT N/A
- ISPC N/A
- AVG Volume (30 Days)
- LYT 12.6M
- ISPC 120.7K
- Earning Date
- LYT 04-09-2025
- ISPC 03-12-2025
- Dividend Yield
- LYT N/A
- ISPC N/A
- EPS Growth
- LYT N/A
- ISPC N/A
- EPS
- LYT 0.30
- ISPC N/A
- Revenue
- LYT $21,363,775.00
- ISPC $10,390,702.00
- Revenue This Year
- LYT N/A
- ISPC $13.82
- Revenue Next Year
- LYT N/A
- ISPC $11.76
- P/E Ratio
- LYT $0.90
- ISPC N/A
- Revenue Growth
- LYT 12.39
- ISPC 0.74
- 52 Week Low
- LYT $0.22
- ISPC $1.73
- 52 Week High
- LYT $18.62
- ISPC $11.80
- Technical
- Relative Strength Index (RSI)
- LYT 28.93
- ISPC 32.34
- Support Level
- LYT $0.22
- ISPC $1.76
- Resistance Level
- LYT $0.54
- ISPC $1.99
- Average True Range (ATR)
- LYT 0.05
- ISPC 0.16
- MACD
- LYT 0.01
- ISPC 0.02
- Stochastic Oscillator
- LYT 12.20
- ISPC 2.13
About LYT Lytus Technologies Holdings PTV. Ltd.
Lytus Technologies Holdings Pvt Ltd is a platform services company providing content streaming/telecasting services to users located all across India. Its scope of business also covers telemedicine services with local assistance through local Health Centers. Through its platform, the customers are well connected via customer premises equipment (CPE) devices/set-top boxes (STBs) and have access to multi-dimensional services including telemedicine service.
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.